Predictive value of CEA and CA 15-3 in the follow up of invasive breast cancer

Anticancer Research

Volumn 19, Issue 4 A, 1999, Pages 2567-2570

  Sutterlin M ^a   Bussen, S ^b   Trott, S ^b   Caffier, H ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b NONE

Author keywords

Breast cancer; CA 15 3; CEA; Follow up; Tumor marker

Indexed keywords

CA 15-3 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

ADULT; AGED; BLOOD LEVEL; BREAST CANCER; CANCER RECURRENCE; CLINICAL TRIAL; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DISEASE COURSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CA-15-3 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM INVASIVENESS; PREDICTIVE VALUE OF TESTS; RECURRENCE; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 18844474422     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (11)

1. Boccardo F, Bruzzi P, Cionini L et al: Appropriateness of the use of clinical and radiologic examinations and laboratory tests in the follow-up of surgically-treated breast cancer patients. Ann Oncol 6(2): 57-59, 1995.
2. Gion M, Barioli P, Mione R et al: Tumor markers in breast cancer follow-up: A potentially useful parameter still awaiting definitive assessment. Ann Oncol 6(2): 31-35, 1995.
3. Hayes DF: Tumor markers for breast cancer. Ann Oncol 4: 807-819, 1993.
4. Sütterlin M, Oehler MK, Caffier H: Clinical value of CYFRA 8/18 and TPS in the diagnosis and follow up of invasive breast cancer. Anticancer Res 17: 2963-2966, 1997.
5. Nicolini A, Colombini C, Luciani L, Carpi A, Giuliani L: Evaluation of serum CA 15-3 determination with CEA and TPA in the post-operative follow-up of breast cancer patients. Br J Cancer 64: 154-158, 1991.
6. Bombardieri E, Pizzichetta M, Veronesi P, Seregni E, Bogni A et al: CA 15.3 determination in patients with breast cancer: clinical utility for the detection of distant metastases. Eur J Cancer 29A: 144-146, 1993.
7. Vizcarra E, Lluch A, Cibrian R, Jarque F, Garcia-Conde J: CA 15.3, CEA and TPA tumor markers in the early diagnosis of breast cancer relapse. Oncology 51: 491-496, 1994.
8. Hayes DF, Zurawski VR, Kufe DW: Comparison of circulating CA 15-3 and carcinoembryonic antigen levels in patients with breast cancer. J Clin Oncol 4: 1542-1550, 1986.
9. Maffei S, Rudoni M, Antonini G, Sacchetti G, Krengli M: CA 15-3 in associazione a CEA e TPA nel follow-up del carcinoma mammario. Minerva Med 81: 759-763, 1990.
10. Barak M, Steiner M, Finkel B, Abrahamson J, Antal S, Gruener N: CA-15.3, TPA and MCA as markers for breast cancer. Eur J Cancer 26: 577-580, 1990.
11. Kallioniemi OP, Oksa K, Aaran RK, Hietanen T, Lehtinen M, Koivula T: Serum CA 15-3 assay in the diagnosis and follow-up of breast cancer. Br J Cancer 58: 213-215, 1988.